HERLAPSA 250MG

What is HERLAPSA 250MG?

HERLAPSA 250MG is a prescription medicine that contains Lapatinib as its active ingredient. It belongs to a class of drugs known as tyrosine kinase inhibitors (TKIs). This medication is primarily used in the treatment of certain types of breast cancer that are HER2-positive, meaning the cancer cells grow due to an overproduction of the HER2 protein. HERLAPSA 250MG works by blocking the action of specific enzymes that promote cancer cell growth and multiplication.

---

What is the Use of HERLAPSA 250MG?

HERLAPSA 250MG is mainly used for:

• Treatment of advanced or metastatic breast cancer in patients who are HER2-positive.

• Often prescribed in combination with Capecitabine or Letrozole for better therapeutic outcomes.

• Used when other cancer treatments (such as Trastuzumab) have not been fully effective.

---

Benefits of HERLAPSA 250MG

• Targets cancer cells selectively by blocking HER2 and EGFR receptors, reducing tumor growth.

• Helps slow down or stop the progression of cancer in patients with advanced breast cancer.

• Can be combined with other therapies for enhanced effectiveness.

• Oral medication – easy to take and manage at home under medical supervision.

---

How Does HERLAPSA 250MG Work?

Lapatinib in HERLAPSA 250MG inhibits the tyrosine kinase domains of HER2 (ErbB2) and EGFR (ErbB1) receptors. By blocking these pathways, it prevents the activation of cellular signals that stimulate cancer cell growth and survival.

---

Side Effects of HERLAPSA 250MG

Like all cancer medications, HERLAPSA 250MG may cause some side effects. Common side effects include:

• Nausea or vomiting

• Diarrhea

• Fatigue or weakness

• Skin rash or dryness

• Loss of appetite

• Hand-foot syndrome (redness or swelling of palms and soles)

• Liver enzyme abnormalities

Serious side effects (seek medical help immediately):

• Severe diarrhea or dehydration

• Signs of liver problems (yellowing of skin or eyes, dark urine)

• Difficulty breathing or irregular heartbeat

---

Precautions and Warnings

• Use only under the supervision of an oncologist.

• Regular liver function tests are recommended during treatment.

• Not recommended for use during pregnancy or breastfeeding.

• Inform your doctor about all medications you are taking to avoid drug interactions.

---

Storage Instructions

• Store in a cool, dry place below 30°C.

• Keep away from moisture, heat, and direct sunlight.

• Keep out of reach of children.

1. What is HERLAPSA 250MG?
HERLAPSA 250MG is a cancer-fighting medicine containing Lapatinib, a tyrosine kinase inhibitor used to treat HER2-positive breast cancer. It works by blocking signals that cause cancer cells to grow and multiply.

---

2. What is HERLAPSA 250MG used for?
It is used for the treatment of advanced or metastatic breast cancer that overexpresses the HER2 protein. It is often prescribed when other treatments like Trastuzumab have not been effective.

---

3. How does HERLAPSA 250MG work?
HERLAPSA 250MG targets and inhibits HER2 and EGFR receptors, which are proteins that promote cancer cell growth. By blocking these receptors, the medicine helps slow down or stop cancer progression.

---

4. How should I take HERLAPSA 250MG?
Take HERLAPSA 250MG by mouth, at least 1 hour before or after a meal, as directed by your oncologist. Swallow the tablets whole with water. Do not crush or chew the tablets.

---

5. Can HERLAPSA 250MG be taken with food?
No. HERLAPSA 250MG should be taken on an empty stomach — either one hour before or one hour after eating — for proper absorption.

---

6. What are the common side effects of HERLAPSA 250MG?
Common side effects include nausea, diarrhea, rash, fatigue, loss of appetite, and liver enzyme changes. These effects are usually manageable under medical supervision.

---

7. Are there any serious side effects I should be aware of?
Yes. Contact your doctor immediately if you experience severe diarrhea, yellowing of the skin or eyes, dark urine, shortness of breath, or chest pain — these could indicate liver or heart problems.

---

8. Can HERLAPSA 250MG be used with other medicines?
It is often used in combination with Capecitabine or Letrozole for better results. However, always inform your doctor about all medications or supplements you are taking to avoid drug interactions.

---

9. How long should I continue taking HERLAPSA 250MG?
Treatment duration depends on your response to therapy and medical condition. Do not stop the medicine without consulting your oncologist.

---

10. Is HERLAPSA 250MG a chemotherapy medicine?
Yes, HERLAPSA 250MG is considered a targeted oral chemotherapy drug that specifically targets cancer cell receptors, making it more focused than traditional chemotherapy.

---

11. Can HERLAPSA 250MG affect liver function?
Yes. HERLAPSA may cause elevated liver enzymes. Regular liver function tests (LFTs) are essential during treatment to monitor for possible liver-related side effects.

---

12. What precautions should I take while using HERLAPSA 250MG?

• Take only under medical supervision.

• Avoid alcohol and grapefruit juice.

• Do not miss doses.

• Inform your doctor if you are pregnant, breastfeeding, or planning pregnancy.

---

13. Can pregnant or breastfeeding women take HERLAPSA 250MG?
No. HERLAPSA 250MG is not recommended during pregnancy or breastfeeding, as it can harm the baby. Use effective contraception during treatment and for some time after the last dose.

---

14. What should I do if I miss a dose of HERLAPSA 250MG?
If you miss a dose, skip the missed dose and continue with your regular schedule. Do not double up to make up for a missed tablet.

---

15. How should I store HERLAPSA 250MG tablets?
Store the tablets at room temperature (below 30°C), in a cool, dry place, away from sunlight and moisture. Keep out of reach of children and pets.